Case reports: Two femoral insufficiency fractures after long-term alendronate therapy

Clinical Orthopaedics and Related Research

Volumn 467, Issue 7, 2009, Pages 1921-1926

  Sayed Noor, Arkan S ^a   Sjödén, Göran O ^a,b  

^a SUNDSVALL HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANALGESIC AGENT; C REACTIVE PROTEIN; VITAMIN D; BONE DENSITY CONSERVATION AGENT;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANALGESIA; ANTIBIOTIC THERAPY; ARTICLE; BONE PROSTHESIS; BONE TURNOVER; CASE REPORT; FEMALE; FEMORAL INSUFFICIENCY FRACTURE; FEMUR FRACTURE; FEMUR SHAFT; FEMUR SUBTROCHANTERIC FRACTURE; FOLLOW UP; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HIP RADIOGRAPHY; HUMAN; IMPLANTATION; INTRAMEDULLARY NAILING; KNEE RADIOGRAPHY; LEG PAIN; LONG TERM CARE; OPEN REDUCTION; OSTEOARTHRITIS; OSTEOSYNTHESIS; PERIPROSTHETIC FEMORAL FRACTURE; PHYSICAL EXAMINATION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSTHESIS; RADIUS FRACTURE; RANGE OF MOTION; THROMBOSIS PREVENTION; TREATMENT DURATION; WEIGHT BEARING; BONE NAIL; BONE REMODELING; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; MIDDLE AGED; RADIOGRAPHY;

AGED; ALENDRONATE; ARTHROPLASTY, REPLACEMENT, HIP; BONE DENSITY CONSERVATION AGENTS; BONE NAILS; BONE REMODELING; FEMALE; FEMORAL FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 67649742849     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-009-0725-x     Document Type: Article

References (26)

1. D Black A Schwartz K Ensrud A Rybak-Feiglin J Gupta A Lombardi R Wallace S Levis S Quandt S Satterfield J Cauley S Cummings 2004 A 5 year randomized trial of the long-term efficacy and safety of alendronate J Bone Mineral Res. 10 suppl 1 S45
2. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet. 348 1535 1541 8950879 10.1016/S0140-6736(96)07088-2 1:CAS:528: DyaK2sXisFCktQ%3D%3D (Pubitemid 26411651)
3. HG Bone W Schurr 2004 Intravenous bisphosphonate therapy for osteoporosis: where do we stand? Curr Osteoporos Rep. 2 24 30 16036079 10.1007/s11914-004-0011-5
4. J Chalmers 1970 Subtrochanteric fractures in osteomalacia J Bone Joint Surg Br. 52 509 513 5455081 1:STN:280:DyaE3c3otFSisw%3D%3D
5. RK Cheung KK Leung KC Lee TC Chow 2007 Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate Hong Kong Med J. 13 485 489 18057440
6. SR Cummings DM Black DE Thompson WB Applegate E Barrett-Connor TA Musliner L Palermo R Prineas SM Rubin JC Scott T Vogt R Wallace AJ Yates AZ LaCroix 1998 Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA. 280 2077 2082 9875874 10.1001/jama.280.24.2077 1:CAS:528: DyaK1MXjsVWruw%3D%3D (Pubitemid 29014065)
7. JD Currey 1984 Effects of differences in mineralization on the mechanical properties of bone Philos Trans R Soc Lond B Biol Sci. 304 509 518 6142490 10.1098/rstb.1984.0042 1:STN:280:DyaL2c7ksFWnug%3D%3D
8. J Esterberg RA Kassim J Redmon J Coad GS Macari KJ Saleh 2003 Hip pain in a case of hypophosphatemic osteomalacia Am J Orthop. 32 455 458 14560828
9. H Fleisch 1998 Bisphosphonates: mechanisms of action Endocr Rev. 19 80 100 9494781 10.1210/er.19.1.80 1:CAS:528:DyaK1cXhtlagtLw%3D
10. TJ Gill JB Sledge R Orler R Ganz 1999 Lateral insufficiency fractures of the femur caused by osteopenia and varus angulation: a complication of total hip arthroplasty J Arthroplasty. 14 982 987 10614891 10.1016/S0883-5403(99)90014-1 1:STN:280:DC%2BD3c%2FotVGmtg%3D%3D
11. SK Goh KY Yang JS Koh MK Wong SY Chua DT Chua TS Howe 2007 Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution J Bone Joint Surg Br. 89 349 353 17356148 10.1302/0301-620X.89B3.18146 (Pubitemid 46563912)
12. M Kleerekoper 2005 Prevention of postmenopausal bone loss and treatment of osteoporosis Semin Reprod Med. 23 141 148 15852199 10.1055/s-2005-869481 (Pubitemid 40604899)
13. ZS Kundu KM Marya A Devgan V Yadav S Rohilla 2004 Subtrochanteric fracture managed by intramedullary nail in a patient with pycnodysostosis Joint Bone Spine. 71 154 156 15050203 10.1016/S1297-319X(03)00143-X (Pubitemid 38407227)
14. EB Kwek SK Goh JS Koh MA Png TS Howe 2008 An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 39 224 231 18222447 10.1016/j.injury.2007.08.036
15. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med. 358 1304 1306 18354114 10.1056/NEJMc0707493 1:CAS:528:DC%2BD1cXjvVarsb8%3D
16. H Lindahl 2007 Epidemiology of periprosthetic femur fracture around total hip arthroplasty Injury. 38 651 654 17477925 10.1016/j.injury.2007.02.048 (Pubitemid 46726315)
17. G Morgan M Ganapathi S Afzal AJ Grant 2002 Pathological fractures in primary hyperparathyroidism: a case report highlighting diagnostic difficulties Injury. 33 288 291 12084655 10.1016/S0020-1383(01)00134-6 1:STN:280: DC%2BD38zkt1Shug%3D%3D (Pubitemid 34669841)
18. AS Neviaser JM Lane BA Lenart F Edobor-Osula DG Lorich 2008 Low-energy femoral shaft fractures associated with alendronate use J Orthop Trauma. 22 346 350 18448990 10.1097/BOT.0b013e318172841c (Pubitemid 351630250)
19. CV Odvina JE Zerwekh DS Rao N Maalouf FA Gottschalk CY Pak 2005 Severely suppressed bone turnover: a potential complication of alendronate therapy J Clin Endocrinol Metab. 90 1294 1301 15598694 10.1210/jc.2004-0952 1:CAS:528:DC%2BD2MXisVOhsr0%3D (Pubitemid 40463979)
20. S Ott 2005 Long-term safety of bisphosphonates. Editorial J Clin Endocrinol Metab. 90 1897 1899 15758064 10.1210/jc.2005-0057 1:CAS:528:DC%2BD2MXisVOhu7w%3D (Pubitemid 40464065)
21. F Pauwels 1948 The significance of the structural principles of the locomotor apparatus to resist the forces applied on long bones Anat Embryol. 114 1 2 10.1007/BF00523553 [in German]
22. VG Roth 1976 Pycnodysostosis presenting with bilateral subtrochanteric fractures: case report Clin Orthop Relat Res. 117 247 253 1277671
23. AS Sayed-Noor GO Sjödén 2008 Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy: a case report Acta Orthop. 79 565 567 18766492 10.1080/17453670710015580
24. JP Schneider 2006 Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate Geriatrics. 61 31 33 16405362
25. CM Schnitzler JR Wing KA Gear HJ Robson 1990 Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis Clin Orthop Relat Res. 261 268 275 2245557
26. RP Tonino PJ Meunier R Emkey JA Rodriguez-Portales CJ Menkes RD Wasnich HG Bone AC Santora M Wu R Desai PD Ross 2000 Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women J Clin Endocrinol Metab. 85 3109 3115 10999794 10.1210/jc.85.9.3109 1:CAS:528:DC%2BD3cXmsVKru70%3D